---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-093434"
form_type: "8-K"
ticker: "GPCR"
cik: "0001888886"
company_name: "Structure Therapeutics Inc."
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:28:46.320497+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Structure Therapeutics appoints Angus Russell to Board, Audit Committee

## Summary
- Angus Russell appointed Class I director effective Aug 26, 2024; term expires at 2027 annual meeting.
- Russell joins Audit Committee; Ted Love, M.D. transitioned off the Audit Committee.
- Granted option for 75,000 ordinary shares (25,000 ADS) vesting over 36 months.
- Annual cash retainers: $45,000 for Board service plus $10,000 for Audit Committee, prorated for 2024.
- Board determined Russell independent under Nasdaq standards and meets audit committee requirements.

## SEC filing metadata
- accession: 0001104659-24-093434
- form_type: 8-K
- ticker: GPCR
- cik: 0001888886
- company_name: Structure Therapeutics Inc.
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/0001104659-24-093434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/tm2422732d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-093434
- JSON: https://secwatch.observer/filing/0001104659-24-093434.json
- Plain text: https://secwatch.observer/filing/0001104659-24-093434.txt

## Key facts
- Executive change
  Angus Russell was appointed as Class I director at Structure Therapeutics Inc..
  - Action: appointed
  - Role: Class I director
  source text: appointed Angus Russell to the Board, effective August 26, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1888886/000110465924093434/0001104659-24-093434-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.